UK approves GSK COVID drug, appears effective against Omicron
New tool helps people decide how best to protect themselves and others from COVID-19
1 December 2021Cancer patients overlooked in COVID-19 vaccine rollout
2 December 2021UK approves GSK COVID drug, appears effective against Omicron
British regulators on Thursday approved a GlaxoSmithKline drug to treat those at high risk of developing severe COVID-19 symptoms, with the manufacturer saying it appears effective against the new Omicron variant.
